In: Sydor AM, Pancotti R, editors
Its difficult to distinguish direct anti-inflammatory effects from the benefits of weight loss and improved metabolic health, but the pattern is consistent enough to warrant further study. A 2025 study found that RA patients with a BMI over 27 taking GLP-1 medications showed improvements in symptoms and disease activity
Which provider is easier to cancel
If youre an Aetna member considering these treatments, its essential to understand your coverage options
Lactobacillus reuteri can increase the content of C16-carnitine in the intestine, thereby effectively activating the Nrf2/HO-1 signaling pathway to resist hepatic IRI [238]
[DOI] [Google Scholar] Leng X., Wu X., Tian J., Li X., Guan L., Weng D